یکشنبه 2 دی 1403
[Archive]
دوره 31، شماره 145 - ( 12-1401 )
جلد 31 شماره 145 صفحات 124-117 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tahani M, Goodarzi M T, Ahmadi A A, Hasani M H, Farrahi A, Mehrzad Selakjani A. Single-Nucleotide Polymorphism of rs11061971 (+219 A>T) in Adiponectin Receptor 2 (AdipoR2) Gene and its Association with Risk of Type 2 Diabetes among Iranian Population. J Adv Med Biomed Res 2023; 31 (145) :117-124
URL: http://journal.zums.ac.ir/article-1-6727-fa.html
URL: http://journal.zums.ac.ir/article-1-6727-fa.html
Single-Nucleotide Polymorphism of rs11061971 (+219 A>T) in Adiponectin Receptor 2 (AdipoR2) Gene and its Association with Risk of Type 2 Diabetes among Iranian Population. Journal of Advances in Medical and Biomedical Research. 1401; 31 (145) :117-124
چکیده: (11286 مشاهده)
Background and Objective: Genetic modifications in the adiponectin receptor 2 (AdipoR2) gene can affect phenotypes associated with insulin resistance and diabetes. The purpose of this study was to evaluate the possible role of genetic modifications in the AdipoR2 gene, to determine the frequency of genotypes and polymorphism alleles of this gene at rs11061971 (+219 A>T), and to investigate its correlation with type 2 diabetes (T2D) and its related metabolic profile.
Materials and Methods: In this case-control study, the single-nucleotide polymorphism (SNP) of AdipoR2 in 116 T2D patients and 102 controls was evaluated using RFLP PCR and FOK 1 enzyme. Fasting blood sugar, cholesterol, triglyceride, insulin, HDL-C, LDL-C and HbA1c were also measured and their correlation with the studied genetic modifications was assessed. The collected data were analyzed using Chi-square test and Hardy-Weinberg equation.
Results: There was a significant association in AT and TT genotypes in rs11061971 (+219 A>T) with T2D. However, no significant difference was observed in the frequency of alleles between the case and control groups. In addition, in LDL-C and total cholesterol in the control group, there was a significant difference between AA and TT genotypes as well as with AA and AT genotypes. However, no correlation was found between the other studied serum parameters and the genotype of individuals in the rs1106197171 polymorphism.
Conclusion: It can be concluded that rs11061971 (+219 A>T) polymorphism is associated with T2D incidence. The findings suggest that AT and TT genotypes in this gene compared to AA genotype increase the risk of diabetes.
نوع مطالعه: مقاله پژوهشی |
موضوع مقاله:
Medical Biology
دریافت: 1400/10/30 | پذیرش: 1401/5/4 | انتشار: 1401/12/22
دریافت: 1400/10/30 | پذیرش: 1401/5/4 | انتشار: 1401/12/22
فهرست منابع
1. Khodaeian M, Enayati S, Tabatabaei-Malazy O, Amoli MM. Association between genetic variants and diabetes mellitus in Iranian populations: a systematic review of observational studies. J Diabet Res. 2015;2015: 585917 [DOI:10.1155/2015/585917] [PMID] [PMCID]
2. Rossi G. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2010;33(Supplement 1):S62-9. [DOI:10.2337/dc10-S062] [PMID] [PMCID]
3. Akrami SM. Genetic counseling in diabetes. J Diabet Metab Disorder. 2007; 6: 205- 13.
4. Haghdoost AA, Rezazadeh-Kermani M, Sadghirad B, Baradaran HR. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis.East Mediterr Health.2009;15(3):591-9 [DOI:10.26719/2009.15.3.591] [PMID]
5. Rider JR, Fiorentino M, Kelly R, et al. Tumor expression of adiponectin receptor 2 and lethal prostate cancer. Carcinogenesis. 2015;36(6):639-47. [DOI:10.1093/carcin/bgv048] [PMID] [PMCID]
6. Alimi M, Goodarzi MT, Nekoei M. Association of ADIPOQ rs266729 and rs1501299 gene polymorphisms and circulating adiponectin level with the risk of type 2 diabetes in a population of Iran: a case-control study. J Diabet Metab Disorder. 2021; 6:1-7. [DOI:10.1007/s40200-020-00715-w] [PMID] [PMCID]
7. Lim S, Quon MJ, Koh KK. Modulation of adiponectin as a potential therapeutic strategy. Atherosclerosis. 2014;233(2):721-8. [DOI:10.1016/j.atherosclerosis.2014.01.051] [PMID]
8. Peters KE, Beilby J, Cadby G, et al. A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome. BMC Med Genet. 2013;14(1):1-2. [DOI:10.1186/1471-2350-14-15] [PMID] [PMCID]
9. Esfahani M, Movahedian A, Baranchi M, Goodarzi MT. Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci. 2015;18(5):430.
10. Goodarzi MT. Adiponectin and metabolic syndrome prevention. Avicenna J Med Biochem, 2014; 2(1): e21991. [DOI:10.17795/ajmb-21991]
11. Zha D, Wu X, Gao P. Adiponectin and its receptors in diabetic kidney disease: molecular mechanisms and clinical potential. Endocrinol. 2017;158(7):2022-34. [DOI:10.1210/en.2016-1765] [PMID]
12. Namvaran F, Rahimi-Moghaddam P, Azarpira N, Dabbaghmanesh MH. Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an Iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus. Molec Biol Rep. 2012; 39(5):5511-8. [DOI:10.1007/s11033-011-1354-5] [PMID]
13. Frankenberg AD, Reis AF, Gerchman F. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review. Arch Endocrinol Metab. 2017;61:614-22. [DOI:10.1590/2359-3997000000316] [PMID]
14. Hosseini H, Teimouri M, Shabani M, et al. Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway. Int J Biochem Cell Biol. 2020;119:105667. [DOI:10.1016/j.biocel.2019.105667] [PMID]
15. Mora-García G, Ruiz-Díaz MS, Espitia-Almeida F, Gómez-Camargo D. Variations in ADIPOR1 but not ADIPOR2 are associated with hypertriglyceridemia and diabetes in an admixed Latin American population. Rev Diabet Stud. 2017;14(2-3):311. [DOI:10.1900/RDS.2017.14.311] [PMID] [PMCID]
16. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Rev. 2005;26(3):439-51. [DOI:10.1210/er.2005-0005] [PMID]
17. Crimmins NA, Martin LJ. Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Obesit Rev. 2007; 8(5):419-23. [DOI:10.1111/j.1467-789X.2007.00348.x] [PMID]
18. Inukai K, Nakashima Y, Watanabe M, et al. Regulation of adiponectin receptor gene expression in diabetic mice. Am J Physiol Endocrinol Metab. 2005;288(5):E876-82. [DOI:10.1152/ajpendo.00118.2004] [PMID]
19. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003; 423(6941):762-9. [DOI:10.1038/nature01705] [PMID]
20. Potapov VA, Chistiakov DA, Dubinina A, Shamkhalova MS, Shestakova MV, Nosikov VV. Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev Diabet Stud. 2008;5(1):28. [DOI:10.1900/RDS.2008.5.28] [PMID] [PMCID]
21. Kim JT, Kim Y, Cho YM, et al. Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. Clin Endocrinol. 2009; 70(1):66-74. [DOI:10.1111/j.1365-2265.2008.03296.x] [PMID]
22. Bermúdez VJ, Rojas E, Toledo A, et al. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes. Am J Therap. 2013; 20(4):414-21. [DOI:10.1097/MJT.0b013e318235f206] [PMID]
23. Rasmussen-Torvik LJ, Pankow JS, Jacobs DR, Steinberger J, Moran A, Sinaiko AR. The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents. Hum Genet. 2009;125(1):21-8. [DOI:10.1007/s00439-008-0595-4] [PMID] [PMCID]
24. Damcott CM, Ott SH, Pollin TI, et al. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the old order amish. Diabet. 2005;54(7):2245-50. [DOI:10.2337/diabetes.54.7.2245] [PMID]
25. Ismail JM,Hussain MK, Mohammad HJ. Common variants in the adiponectin receptor 2 (adipor2) gene is associated in T2DM patients in with and without cardiovascular disease and adiponectin levels. Int J Res Appl Nat Soc Sci. 2016; 4(4): 81-88. [DOI:10.21474/IJAR01/211]
26. Richardson DK, Schneider J, Fourcaudot MJ, et al.Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia. 2006; 49(10):2317-28. [DOI:10.1007/s00125-006-0384-3] [PMID]
27. Collins SC, Luan J, Thompson AJ, et al. Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations. Diabetologia. 2007; 50(3):555-62. [DOI:10.1007/s00125-006-0534-7] [PMID] [PMCID]
28. Kobayashi H, Otsuka H, Yanai M, et al. Adiponectin receptor gene polymorphisms are associated with kidney function in elderly Japanese populations. J Atheroscler Thromb. 2018:45609.
29. Khodyrev DS, Nikitin AG, Brovkin AN, et al. Association of polymorphisms of the ADIPOQ, ADIPOR1 and ADIPOR2 genes with type 2 diabetes mellitus. Diabet Mellitus. 2015; 18(2):5-11. [DOI:10.14341/DM201525-11]
30. Hussain MK, Deli FA, Abdul-Rudha KH. Adiponectin receptor 1 gene polymorphisms (rs1342387 & rs12733285) are not associated directly with type 2 diabetes mellitus in Iraqi population. Gene Rep. 2019;14:45-9. [DOI:10.1016/j.genrep.2018.11.006]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
